Mangoceuticals (MGRX) Non Operating Income (2023 - 2026)

Mangoceuticals has disclosed Non Operating Income across 4 years of filings, most recently posting -$276815.0 for Q1 2026.

• Non Operating Income for Q1 2026 came in at -$276815.0, down 5.21% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.9 million (down 190.64% YoY), and the FY2025 annual result was -$2.6 million, down 255.14% from the prior year.
• Non Operating Income came in at -$276815.0 for Q1 2026 at Mangoceuticals, up from -$2.4 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $8233.0 in Q2 2023 to a low of -$2.4 million in Q4 2025.
• The 4-year median for Non Operating Income is -$232149.0 (2024), against an average of -$389349.6.
• Across the five-year window, Non Operating Income sank 2804.7% in 2024 and surged 68.61% in 2025, its largest moves.
• Mangoceuticals' Non Operating Income stood at $8233.0 in 2023, then slumped by 3390.84% to -$270935.0 in 2024, then tumbled by 786.42% to -$2.4 million in 2025, then soared by 88.47% to -$276815.0 in 2026.
• The last three Non Operating Income figures came in at -$276815.0 (Q1 2026), -$2.4 million (Q4 2025), and -$75850.0 (Q3 2025), per Business Quant data.